Compare CTSO & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | DXLG |
|---|---|---|
| Founded | 1997 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.5M | 38.4M |
| IPO Year | 2008 | 1994 |
| Metric | CTSO | DXLG |
|---|---|---|
| Price | $0.45 | $0.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.38 | $1.50 |
| AVG Volume (30 Days) | 77.1K | ★ 93.1K |
| Earning Date | 05-01-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.79 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $22,503,908.00 | ★ $435,017,000.00 |
| Revenue This Year | $10.34 | $3.85 |
| Revenue Next Year | $22.41 | $4.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.53 | N/A |
| 52 Week Low | $0.44 | $0.44 |
| 52 Week High | $1.39 | $1.69 |
| Indicator | CTSO | DXLG |
|---|---|---|
| Relative Strength Index (RSI) | 28.17 | 61.31 |
| Support Level | N/A | $0.48 |
| Resistance Level | $0.74 | $0.82 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 8.67 | 58.35 |
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store and Direct business. The company have two principal operating segments: company's stores and direct business.